Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression

M Stampanoni Bassi, L Gilio, P Maffei… - Frontiers in Molecular …, 2018 - frontiersin.org
The endocannabinoid system (ECS) has been recently recognized as a prominent promoter
of the emotional homeostasis, mediating the effects of different environmental signals …

The endocannabinoid system in mental disorders: Evidence from human brain studies

I Ibarra-Lecue, F Pilar-Cuéllar, C Muguruza… - Biochemical …, 2018 - Elsevier
Mental disorders have a high prevalence compared with many other health conditions and
are the leading cause of disability worldwide. Several studies performed in the last years …

Circulating endocannabinoids and psychological outcomes in women with PTSD

C Botsford, AG Brellenthin, JM Cisler, CJ Hillard… - Journal of anxiety …, 2023 - Elsevier
Background Recent research has attempted to elucidate the relationship between blood-
based biomarkers (eg, endocannabinoids; eCBs: including N-arachidonoylethanolamine …

The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants

MN Hill, CJ Hillard, FR Bambico, S Patel… - Trends in …, 2009 - cell.com
The endocannabinoid system is a neuromodulatory system which is known to regulate
emotional, cognitive, neurovegetative and motivational processes. Substantial evidence has …

The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a …

N Aisenberg, L Serova, EL Sabban, I Akirav - European …, 2017 - Elsevier
Current clinical and pre-clinical data suggest that both cannabinoid agents and blockage of
CRF through corticotrophin releasing factor receptor type 1 (CRFr1) may offer therapeutic …

Endocannabinoid signals in the control of emotion

B Lutz - Current opinion in pharmacology, 2009 - Elsevier
The appropriate control of emotional responses evoked by environmental stimuli is an
important innate mechanism for ensuring quality of life and even for survival. Inappropriate …

Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies

DR Janero, SK Vadivel… - International Review of …, 2009 - Taylor & Francis
Medicinal chemistry has produced small-molecule agents with drug-like character that
potently and safely modulate the activity of discrete endocannabinoid system components …

Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression

A Segev, AS Rubin, H Abush, G Richter-Levin… - …, 2014 - nature.com
Most psychiatric disorders are characterized by emotional memory or learning disturbances.
Chronic mild stress (CMS) is a common animal model for stress-induced depression. Here …

High times for painful blues: the endocannabinoid system in pain-depression comorbidity

M Fitzgibbon, DP Finn, M Roche - International Journal of …, 2016 - academic.oup.com
Depression and pain are two of the most debilitating disorders worldwide and have an
estimated cooccurrence of up to 80%. Comorbidity of these disorders is more difficult to treat …

Endocannabinoid system in psychotic and mood disorders, a review of human studies

R Garani, JJ Watts, R Mizrahi - Progress in Neuro-Psychopharmacology …, 2021 - Elsevier
Despite widespread evidence of endocannabinoid system involvement in the
pathophysiology of psychiatric disorders, our understanding remains rudimentary. Here we …